Principal Investigator
Angela Schulz, MD
UKE - Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(1)
1 unique interventions1 categories
Analytics
Trial Phases
Phase 31
Trial Status
Other1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
3 collaborators·3 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
UKE - Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
3 similar investigators found
Kathrin C Meyer, PhD
Neela Therapeutics
1 trials
Shared therapeutic areas:
CLN3
Similarity Score30%
Gary D Clark, MD
Texas Children Hospital Houston, Texas, United States, 77030
1 trials
Shared therapeutic areas:
CLN3
Worked with same sponsors:
Beyond Batten Disease FoundationTheranexus
Collaborated on 1 trial
Similarity Score14%
Paul Gissen, MD PhD
Great Ormond Street Hospital, London United Kingdom, WC1N 3JH
1 trials
Shared therapeutic areas:
CLN3
Worked with same sponsors:
Beyond Batten Disease FoundationTheranexus
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) Disease
CLN3
All 1 trials loaded